Amplified Sciences, LLC

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Request demo

Amplified Sciences, LLC - overview

About

Based in Indiana, US, and founded in 2016 by CEO Diana T. Caldwell and V. Jo Davisson, Amplified Sciences, LLC, a. k.

a. Amplified Sciences is a life science diagnostics company focused on accurately detecting and preempting the risks of debilitating diseases. With operations in Purdue Research Park and key alliances in San Francisco and Boston, the company’s lead assay is for the early detection of pancreatic cancer. In February 2024, Amplified Sciences, Inc.

raised an amount of USD 0. 108 million in venture funding. The company develops a platform based on ultra-sensitive molecular sensing technology to treat pancreatic cancer. The platform can detect at the single molecule level, scales easily to the point of care, and provides a favorable cost structure for their platform of reagents.

Amplified Sciences plans to use its proceeds from February 2024 funding to develop its tests for early, more accurate detection of challenging diseases, starting with pancreatic cancer.

Current Investors

OCA Ventures, Elevate Ventures, VisionTech Partners

Request a demo

Primary Industry

Biotechnology

Sub Industries

Bioinformatics, Biotechnology

Website

www.amplifiedsciences.com

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.

Request demo